Description

BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited issued on a preferential basis to promoters, effective February 25, 2026. Shares are subject to lock-in until June 16, 2027.

Summary

BSE has notified trading members that 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code: 524314) are listed and permitted to trade on the Exchange effective Wednesday, February 25, 2026. These shares were issued on a preferential basis to promoters at Rs. 37.70 per share (face value Rs. 10 + premium Rs. 27.70).

Key Points

  • 3,71,000 equity shares of Rs. 10/- each issued at a premium of Rs. 27.70 to promoters on a preferential basis
  • Issue price: Rs. 37.70 per share
  • Shares are ranking pari-passu with existing equity shares of the company
  • Distribution numbers: 74,20,301 to 77,91,300
  • Date of allotment: December 16, 2025
  • ISIN: INE499G01013
  • Trading effective from: February 25, 2026

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for newly allotted securities pursuant to a preferential issue.

Compliance Requirements

  • Trading members must note the new securities listed under Scrip Code 524314
  • The entire allotment of 3,71,000 shares is subject to lock-in and cannot be traded until June 16, 2027
  • Lock-in applies to distribution numbers 74,20,301 to 77,91,300

Important Dates

  • Date of Allotment: December 16, 2025
  • Trading Commencement Date: February 25, 2026
  • Lock-in Expiry Date: June 16, 2027

Impact Assessment

The listing of these preferential shares has minimal immediate market impact as all 3,71,000 shares are under lock-in until June 16, 2027, meaning they cannot be freely traded. The allotment increases the total share capital of Gujarat Terce Laboratories Limited. Broader market participants are unlikely to be affected; the primary implication is for the company’s promoter shareholding structure.

Impact Justification

Routine preferential allotment listing for a small number of shares to promoters with a lock-in period. Limited broader market impact as it affects a single small-cap company.